AGAP2-AS1 as a prognostic biomarker in low-risk clear cell renal cell carcinoma patients with progressing disease.

Nakken, Sigrid; Eikrem, Øystein; Marti, Hans-Peter; Beisland, Christian; Bostad, Leif; Scherer, Andreas; Flatberg, Arnar; Beisvag, Vidar; Skandalou, Eleni; Furriol, Jessica; Strauss, Philipp

Nakken, Sigrid; Eikrem, Øystein; Marti, Hans-Peter; Beisland, Christian; Bostad, Leif; Scherer, Andreas; Flatberg, Arnar; Beisvag, Vidar; Skandalou, Eleni; Furriol, Jessica; Strauss, Philipp.

Afiliação

Nakken S; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
Eikrem Ø; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
Marti HP; Department of Medicine, Haukeland University Hospital, 5021, Bergen, Norway.
Beisland C; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
Bostad L; Department of Medicine, Haukeland University Hospital, 5021, Bergen, Norway.
Scherer A; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
Flatberg A; Department of Urology, Haukeland University Hospital, 5021, Bergen, Norway.
Beisvag V; Department of Clinical Medicine, University of Bergen, 5021, Bergen, Norway.
Skandalou E; Department of Pathology, Haukeland University Hospital, 5021, Bergen, Norway.
Furriol J; Spheromics, 81100, Kontiolahti, Finland.
Strauss P; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014, Helsinki, Finland.

Cancer Cell Int ; 21(1): 690, 2021 Dec 20.

Article em En | MEDLINE | ID: mdl-34930263

Palavras-chave

AGAP2-AS1; Biomarker; Low-risk; RNA-seq; ccRCC

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Cell Int Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google